Calosyn Pharma
Shreveport, US · Founded 2007 · Delaware corporation · 1 known investors
Founders & leadership
WR
William R. GrimesPresident and Chief Executive Officer
SS
Stephen SnowdyExecutive
DW
David WaddellNamed on SEC filing
RP
Ross P. BarrettSecretary
Board
JL
Joseph LovettBoard director
RB
Richard BabbTreasurer
MS
Mike ShermanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 2 rounds · 2012–2022
▶$750KraisedMar 2024 · 7 investors · BiotechnologyRule 506(b)
▶$750KraisedMar 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LovettDirector
- Richard BabbExecutive Officer, Director
- David WaddellDirector
- Ross P. BarrettExecutive Officer, Director
- William R. GrimesExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $750K
- Proceeds to insiders
- $144K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$309.7KraisedFeb 2012 · 3 investors · BiotechnologyRule 506(b)
▶$309.7KraisedFeb 2012 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David WaddellDirector
- Stephen SnowdyExecutive Officer, Director
- Ross BarrettDirector
- Joseph LovettDirector
- Mike ShermanDirector
- Offering amount
- $2.1M
- Amount sold
- $309.7K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Calosyn Pharma's investors?
- Calosyn Pharma's investors include Louisiana Funds.
- How much funding has Calosyn Pharma raised?
- Calosyn Pharma has disclosed $1.1M raised across 2 rounds.
- Where is Calosyn Pharma headquartered?
- Calosyn Pharma is headquartered in Shreveport, US.